Colon Health Sensor

Genetic Analysis

EFFECTIVE PREVENTION OF COLORECTAL CANCER

The Colon Health Sensor uses genetic analysis to provide information on the individual risk of colorectal cancer and thus enables targeted prevention.

Colon Health Sensor

The Colon Health Sensor at a glance:

  • Investigation of 17 relevant gene variations
  • Assessment of the genetic risk of colorectal cancer
  • Assessment of the effect of 32 drugs based on their genetic profile
  • Reliable testing in our laboratory
  • Written evaluation of the test results
  • Individual precautionary recommendations based on the results

Bowel cancer is one of the most common types of cancer

Colorectal cancer is one of the most common cancers in the western industrial nations. It is estimated that about six percent of the population is affected during their lifetime, although men are at slightly higher risk than women.

Although a lot has happened in recent years concerning therapy options, in Germany alone, around 27,000 people still die of colorectal cancer every year. Therefore, early diagnosis and treatment are of great importance for a favorable prognosis.

Causes of colorectal cancer

The probability of developing bowel cancer increases sharply with age. Also, unhealthy lifestyle habits, such as excessive consumption of sausage and red meat, contribute significantly to an increase in the risk of bowel cancer.

Apart from this, genes also have a significant influence on the development of colorectal cancer. Therefore, genetic analysis can help assess individual risk factors and, if necessary, one can take timely preventive measures.

How the Colon Health Sensor works

As part of our Colon Health Sensor, our laboratory performs a comprehensive analysis of the sample sent in. We examine a total of 17 gene variations associated with the risk of colorectal cancer.

This allows us to assess the likelihood of a patient developing colorectal cancer and whether special precautions are recommended.

After a successful analysis, in which the individual risk of colorectal cancer Genetic based on the gene profile and the effect of 32 relevant drugs, we prepare a precise evaluation with all results.

Thus, our Colon Health Sensor can make a valuable contribution to effective colorectal cancer screening and help to reduce the patient’s individual risk significantly.

How it works:

Receive the collection kit

Follow the instructions to take your sample

The sample is returned to the laboratory for testing (prepaid envelope included)

Receive results by post and/or by email

Experience the future of genetic testing with Novogenia Laboratory

Every analysis is a step towards a healthier and more informed life. Interested in partnership?

✅ SCIENCE AVAILABLE ON GENES

✅ SCIENCE AVAILABLE ON RECOMMENDATIONS

❌ PROGRAM BASED ON LOGICAL CONCLUSIONS

❌ CUSTOMER FEEDBACK ON EFFECTIVENESS GIVEN

❌ INTERNAL EXPERIMENTS HAVE PROVEN ITS EFFECTIVENESS

❌ EXTERNAL STUDIES HAVE PROVEN THE EFFECTIVENESS OF THE RECOMMENDATION

This analysis is not offered by Novogenia.
It is created and sold by our partner
company DNA PLUS –
Zentrum für Humangenetik GmbH in Germany.

 

You might be also interested in

ShapePlus 

Genetic Weight Loss Analysis.

Gain a personalized understanding of the genetic factors influencing your weight management journey.

VitalityPlus

Genetic Weight and Nutrition Analysis.

Receive detailed answers on how your genetic makeup influences your weight loss goals and nutritional choices.

LifestylePlus

Comprehensive Genetic Wellness Evaluation. 

Gain a personalized understanding of the genetic factors influencing your weight management journey.

Important Information
We do not sell our products directly to end customers, but we would be pleased to hear from you so that we can recommend a suitable partner in your area.